A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinomal Evaluating the Efficacy and Safety

Protocol: 
AAAQ9319
Phase: 
III

A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinomal Evaluating the Efficacy and Safety

Are you Eligible? (Inclusion Criteria)

Inclusion:
1) Naive or recurrent patients with LG, non-invasive UTUC in the pyelocalyceal system.
2) Patient has at least one (1) measurable and biopsy-confirmed papillary LG tumor <= 15 mm
diameter.
Exclusion:
1) Patient received BCG treatment for UTUC during the 6 months prior to Visit 1.
2) Patient has bladder cancer.
3) Patient has a history of invasive and or HG bladder cancer during the past 5 (Five) years.

Trial Location

Herbert Irving Comprehensive Cancer Center
161 Fort Washington Ave.
Herbert Irving Pavilion
New York, NY 10032
United States

ColumbiaDoctors Midtown
51 West 51st St.
New York, NY 10019
United States